BioMatt shares overall responsibilities for all management and investment activities of the firm. Matt has primary responsibility for Arlington’s healthcare investments and shares responsibility for the firm’s aerospace and defense investments. Matt has closed leveraged buyouts, recapitalizations and growth equity investments representing over $2.0 billion in value during his 18 year career in private equity. Matt†....
Education